Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrrolate manufacturers

16 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

16 products found

glycopyrrolate

Injection 0.2 mg/ml - 1 ml , 2 ml , 5 ml , 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #10627
NaN

Manufacturer usually replies in 7 days

glycopyrrolate

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311
This pharmaceutical company specializes in developing and supplying drug products and substances to global markets. Their focus is on innovation and quality, offering both prescription and over-the-counter products. The company boasts strong GMP certifications, ensuring adherence to international standards. Their portfolio likely includes solid dosage forms and may extend to injectables or liquids. While specific therapy areas are not mentioned, the focus on advanced markets suggests specialization in areas like oncology, cardiology, or neurology. With a proven track record of supplying high-quality pharmaceuticals, they likely hold multiple product patents. The company's decades-long presence in the industry, particularly in the European Union and North America, underscores their commitment to global healthcare solutions.

Manufacturer usually replies in 14 days

glycopyrrolate

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 13 days

Want to see all 16 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible